Showing results (171-180 of 197) with videos related to
Sort By:
Pageof 20
Journal of the National Cancer Institute|March 22, 2007
Randomized controlled trial of resection versus radiotherapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancerJan P van Meerbeeck, Gijs W P M Kramer, Paul E Y Van Schil, et al.International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapySuresh Senan, Sjaak Burgers, Michael J Samson, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 21, 2019
Maintenance Defactinib Versus Placebo After First-Line Chemotherapy in Patients With Merlin-Stratified Pleural Mesothelioma: COMMAND-A Double-Blind, Randomized, Phase II StudyDean A Fennell, Paul Baas, Paul Taylor, et al.The European Respiratory Journal|June 6, 2024
A randomised phase II study of extended pleurectomy/decortication preceded or followed by chemotherapy in patients with early-stage pleural mesothelioma: EORTC 1205Jo Raskin, Veerle Surmont, Alexander P W M Maat, et al.Molecular Oncology|December 1, 2022
Preclinical evaluation of CDK4 phosphorylation predicts high sensitivity of pleural mesotheliomas to CDK4/6 inhibitionSabine Paternot, Eric Raspé, Clément Meiller, et al.Cancer Treatment Reviews|June 24, 2014
Novel therapeutic strategies for patients with NSCLC that do not respond to treatment with EGFR inhibitorsChristian Rolfo, Elisa Giovannetti, David S Hong, et al.Anticancer Research|November 27, 2008
Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancerRoger Tell, Christer Sederholm, Claes Klintenberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 14, 2012
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysisKevin Hollevoet, Johannes B Reitsma, Jenette Creaney, et al.The Lancet. Oncology|June 24, 2017
Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trialCorinne Faivre-Finn, Michael Snee, Linda Ashcroft, et al.European Journal of Cancer (Oxford, England : 1990)|February 7, 2020
CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populationsEnriqueta Felip, Andrea Ardizzoni, Tudor Ciuleanu, et al.Pageof 20